1) intra-arterial chemotherapy
动脉化疗
1.
The outcome of bladder-sparing surgery combined with intra-arterial chemotherapy for invasive bladder cancer;
保留膀胱手术联合动脉化疗治疗浸润性膀胱癌的临床研究
2.
Method: 156 cancer patients with an indication of intra-arterial chemotherapy were randomly divided into two groups, 78 cases each receiving cisplatin (≥50mg/m2) and doxorubicin (≥40 mg/m2) respectively in the therapy scheme.
入选病例为具备介入动脉化疗或(和)栓塞治疗适应证且化疗方案中均含有顺铂≥50mg/m~2或(和)阿霉素≥40mg/m~2(吡喃阿霉素≥40mg/m~2,表阿霉素≥80mg/m~2)化疗药物。
3.
Several studies indicates that gemcitabine based intra-arterial chemotherapy may be effective in treating advanced pancreatic cancer.
动脉化疗可以通过对肿瘤动脉的局部灌注使肿瘤组织有较高的药物分布,有研究表明吉西他滨联合药物动脉化疗可能对晚期胰腺癌有效。
2) Artery chemotherapy
动脉化疗
1.
Objective To find out how to choose the doses of hepatic artery chemotherapy(HAC)in hepatic cell carcinoma(HCC) cases with abnormal liver function.
目的 探讨肝功异常的原发性肝癌如何选择动脉化疗剂量。
2.
Then artery chemotherapy was done regularly.
方法：对9例胃癌、结直肠癌肝转移患者行左锁骨下动脉双管置入,行规律动脉化疗。
3) Arterial chemotherapy
动脉化疗
1.
To investigate the influence of preoperative arterial chemotherapy on the expression of p53 and proliferating cell nuclear antigen (PCNA) in bladder cancer.
[目的]探讨术前动脉化疗对膀胱癌p53和增殖细胞核抗原(PCNA)表达的影响及临床意义。
4) Chemotherapy
[英][,ki:məʊ'θerəpi] [美]['kimo'θɛrəpɪ]
动脉化疗
1.
To investigate the effect of systematic chemotherapy combined with Aidi injection transhepatic arterial infusion in treatment for liver cancer.
其中,A组51例周围静脉化疗,B组51例肝动脉化疗,C组52例化疗联合艾迪注射液肝动脉灌注。
5) transcarotid artery chemotherapy
颈动脉化疗
6) hepatic artery chemoembolization
肝动脉化疗
1.
Therapy using baraclude and hepatic artery chemoembolization(TACE)is helpful to prolong the survival for paitents with hepatocellular carcinoma(HCC)with coexisting active hepatitis B;
博路定联合肝动脉化疗对HBsAg(+)肝癌病人生存期的影响
补充资料：锁骨下动脉-锁骨下动脉-颈动脉旁路术
锁骨下动脉-锁骨下动脉-颈动脉旁路术
适用于大动脉炎所致的左锁骨下动脉和左颈总动脉起始处缩窄、闭塞而无名动脉通畅者，无名动脉分叉处缩窄、闭塞而左锁骨下动脉通畅者。手术在全麻下取双侧颈部横切口。显示双侧锁骨下动脉，用0.7～0.8cm口径的人工血管，经胸锁乳突肌后方隧道，作人工血管与锁骨下动脉端-侧吻合。若颈总动脉起始处有缩窄、闭塞者，加作颈部垂直切口，显露颈总动脉，再以等粗人工血管与颈总动脉及移植于两锁骨下动脉间的人工血管分别作端-侧吻合。手术可纠正或改善脑部和左上肢的血液供应。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条